Tirzepatide and Oral Contraceptives: Can You Take Them Together?

Critical — Potentially Dangerousabsorption
Evidence-gradedLast reviewed August 8, 2026Source: FDA prescribing information for MOUNJARO (tirzepatide), Sections 7.2 Oral Medications, 8.3 Females and Males of Reproductive Potential, 17 Patient Counseling Information, and 12.3 Clinical Pharmacology; equivalent text in the ZEPBOUND label. Retrieved from DailyMed.
Learn about each ingredient:TirzepatideOral Contraceptives

Quick answer

Tirzepatide slows how quickly the stomach empties, and that slowing is strongest right after the first dose and after each dose increase. A birth control pill relies on being absorbed promptly and completely; when the stomach holds onto it, peak hormone levels fall by more than half. The FDA label instructs patients on oral hormonal contraceptives to switch to a non-oral method or add a barrier method for four weeks after starting and for four weeks after every dose increase. Contraceptives that are not swallowed are not affected.

Use a backup barrier method, or switch to a non-oral contraceptive such as an implant, IUD, patch, ring or injection, for four weeks after starting tirzepatide and for four weeks after each dose increase. Because doses step up at roughly monthly intervals, this can span most of the titration period — plan for that rather than counting a single four-week window. Discuss the timing with your prescriber.

What happens when you take tirzepatide with the pill?

Tirzepatide slows how fast your stomach empties into the intestine. That slowdown is what blunts appetite and steadies blood sugar after meals — it is a large part of how the medicine works.

A birth control pill, though, depends on being absorbed reasonably quickly and completely. When the stomach holds onto it, peak hormone levels in the blood fall sharply. In the study behind the label, peak levels of ethinyl estradiol dropped by about 59%, and the other hormone components by similar amounts.

Why this matters

Contraceptive pills work by keeping hormone levels above a threshold. Lower peaks can mean falling below what is needed to reliably prevent ovulation.

The FDA is unusually direct here. The label instructs patients using oral hormonal contraceptives to switch to a non-oral method, or add a barrier method, for four weeks after starting tirzepatide and for four weeks after each dose increase. That instruction appears in four separate places on the label and has been there since the drug was first approved in 2022.

The part that is easy to miss

The four-week clock restarts at every dose increase. Tirzepatide is normally titrated upward at roughly monthly intervals, so someone working up to a maintenance dose can be inside a four-week window almost continuously for months. Most summaries mention only "four weeks after starting," which understates it considerably.

What to do

Use a barrier method alongside the pill, or move to a contraceptive that is not swallowed — an implant, IUD, patch, ring or injection. The label is explicit that hormonal contraceptives which are not taken orally are not affected, because they never pass through the stomach.

Talk to your prescriber about which option fits, and about the timing relative to your dose schedule.

Does this apply to other medicines in this family?

No, and that distinction matters. This warning is specific to tirzepatide. Semaglutide was tested against the same contraceptive and did not meaningfully reduce its absorption. Liraglutide's effect on peak levels is around 12%, compared with tirzepatide's 59%. Dulaglutide's label does not mention contraceptives at all.

This is general information, not medical advice. Do not stop or change a prescribed medicine on your own.

Other Tirzepatide interactions

See all →
+ thiaminecritical+ psylliumhigh+ insulinhigh+ glipizidehigh

Other Oral Contraceptives interactions

See all →
+ st. john's wortcritical+ smokingcritical+ folatemoderate+ caffeinemoderate+ vitamin b6low+ magnesiumlow

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

FDA prescribing information for MOUNJARO (tirzepatide), Sections 7.2 Oral Medications, 8.3 Females and Males of Reproductive Potential, 17 Patient Counseling Information, and 12.3 Clinical Pharmacology; equivalent text in the ZEPBOUND label. Retrieved from DailyMed. ↗

Reviewed August 8, 2026. How we grade evidence →

Related Topics

tirzepatidemounjarozepboundoral contraceptivesbirth controlgastric emptyingcontraception

Related Interactions

Other interactions you should know about

Tirzepatide + Psyllium

high

These medicines make the stomach empty much more slowly. Indigestible plant fibre that sits in a slow stomach long enough can mat together into a solid ball called a bezoar. In one endoscopy series, four of twenty-three patients taking a GLP-1 medicine had a gastric bezoar of four centimetres or more, and none of the seventy-seven patients not taking one did. A concentrated fibre supplement adds exactly the material these are formed from. Bulk fibre also swells with water and can lodge in the food pipe if taken with too little fluid.

Oral Contraceptives + Vitamin B6

low

Combined (estrogen-containing) oral contraceptives modestly lower the active form of vitamin B6, pyridoxal 5'-phosphate, by speeding up tryptophan metabolism. Long-term pill users tend to show lower B6 status markers than non-users. This is a depletion of a status marker rather than a clinical safety problem, and it does not affect how well the pill works.

Oral Contraceptives + St. John's Wort

critical

St. John's Wort induces CYP3A4 and P-glycoprotein, increasing the clearance of contraceptive hormones and reducing the effectiveness of hormonal contraceptives.

Oral Contraceptives + Magnesium

low

Observational studies dating back to the 1970s have found that women taking combined oral contraceptives tend to have somewhat lower serum magnesium levels than non-users, likely through estrogen-related shifts in how the body distributes and excretes magnesium. This is a nutritional observation, not a contraceptive-failure risk. Magnesium does not reduce the pill's effectiveness, and links between low magnesium and pill side effects or clotting risk remain theoretical rather than proven.

Smoking + Oral Contraceptives

critical

Combining cigarette smoking with combined (estrogen-containing) oral contraceptives raises the risk of heart attack, stroke, and blood clots more than either exposure alone, especially after age 35 and with heavier smoking.

Oral Contraceptives + Folate

moderate

Combined oral contraceptive use is associated with modestly lower plasma and red blood cell folate levels, likely through increased turnover and urinary excretion. Because fertility can return quickly after stopping the pill, lower folate stores at that moment can matter for the neural tube risk of an early pregnancy.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free